Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
196.40B
Market cap196.40B
Price-Earnings ratio
25.74
Price-Earnings ratio25.74
Dividend yield
2.64%
Dividend yield2.64%
Average volume
2.29M
Average volume2.29M
High today
$368.78
High today$368.78
Low today
$364.30
Low today$364.30
Open price
$368.24
Open price$368.24
Volume
129.61K
Volume129.61K
52 Week high
$391.29
52 Week high$391.29
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

Amgen(AMGN) stock is priced at $364.34, giving the company a market capitalization of 196.4B. It carries a P/E multiple of 25.74 and pays a dividend yield of 2.6%.

As of 2026-03-17, Amgen(AMGN) stock has fluctuated between $364.30 and $368.78. The current price stands at $364.34, placing the stock +0.0% above today's low and -1.2% off the high.

Amgen(AMGN) shares are trading with a volume of 129.61K, against a daily average of 2.29M.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

AMGN News

Benzinga 1d
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

This move will augment the total number of discounted prescription medications available on the platform to 54, from five different pharmaceutical companies, ac...

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
Simply Wall St 1d
Amgen TrumpRx Discounts Put Drug Pricing And Growth Story In Focus

Amgen has partnered with the government run TrumpRx platform to offer deep discounts on key brand name drugs. The agreement covers major products such as Amjev...

Amgen TrumpRx Discounts Put Drug Pricing And Growth Story In Focus
Simply Wall St 3d
How Investors May Respond To Amgen Dividend, Obesity Drug Focus, And Cardiovascular Trial Updates

In early March 2026, Amgen announced a US$2.52 per-share second-quarter dividend payable on June 5, 2026, and presented its growth and pipeline outlook at the L...

How Investors May Respond To Amgen Dividend, Obesity Drug Focus, And Cardiovascular Trial Updates

Analyst ratings

53%

of 38 ratings
Buy
39.5%
Hold
52.6%
Sell
7.9%

More AMGN News

Seeking Alpha 3d
Amgen and GSK said to be adding products on TrumpRx

Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run direct-to-consumer platform for pharmaceutical...

Amgen and GSK said to be adding products on TrumpRx
The Motley Fool 5d
Rapid Micro Earnings Call Transcript

Image source: The Motley Fool. Thursday, March 12, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Robert Spignesi Chief Financi...

Rapid Micro Earnings Call Transcript
Barron's 5d
Starbucks, Amgen, and CVS Help This Income Fund Shine

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...

Starbucks, Amgen, and CVS Help This Income Fund Shine
24/7 Wall St. 7d
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained

Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained Quick Read Jefferies initiated on Gilead (GILD) w...

Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.